HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hiatt, R A Articles by Friedman, G D Search for Related Content PubMed PubMed Citation Articles by Hiatt, R A Articles by Friedman, G D

Characteristics of patients referred for treatment of end-stage renal disease in a defined population.

R A Hiatt and G D Friedman

We studied the incidence of referral for treatment of end-stage renal disease (ESRD) in the Kaiser Foundation Health Plan (KFHP) in northern California from 1972 through 1977. In this population of over 1 million persons, we found an age-adjusted annual incidence of 44.9 per million after 1973, when the Federal ESRD Program went into effect. Age-specific incidence was highest in in men greater than 70 years of age and in women in the 50- to 59-year age group; the male/female ratio was 1.4:1. The most common diagnoses of patients referred with ESRD were glomerulonephritis (11.4 per million per year), diabetic nephropathy (5.0 per million per year), primary hypertensive disease (3.1 per million per year), and polycystic kidney disease (2.4 per million per year). Estimated rates of referral for ESRD were highest for Blacks, lowest for Whites, and intermediate for Asians. Incidence varied by geographic area within the health plan service area and was highest where the percentage of the Black population was highest.

This article has been cited by other articles:

				R. A. Whitmer, A. J. Karter, K. Yaffe, C. P. Quesenberry Jr, and J. V. Selby Hypoglycemic Episodes and Risk of Dementia in Older Patients With Type 2 Diabetes Mellitus JAMA, April 15, 2009; 301(15): 1565 - 1572. [Abstract] [Full Text] [PDF]

				H. H Moffet, N. Adler, D. Schillinger, A. T Ahmed, B. Laraia, J. V Selby, R. Neugebauer, J. Y Liu, M. M Parker, M. Warton, et al. Cohort Profile: The Diabetes Study of Northern California (DISTANCE)--objectives and design of a survey follow-up study of social health disparities in a managed care population Int. J. Epidemiol., February 1, 2009; 38(1): 38 - 47. [Full Text] [PDF]

				D. Ardigo, T. L. Assimes, S. P. Fortmann, A. S. Go, M. Hlatky, E. Hytopoulos, C. Iribarren, P. S. Tsao, R. Tabibiazar, T. Quertermous, et al. Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease Physiol Genomics, November 14, 2007; 31(3): 402 - 409. [Abstract] [Full Text] [PDF]

				A. J. Karter, M. M. Parker, H. H. Moffet, M. M. Spence, J. Chan, S. L. Ettner, and J. V. Selby Longitudinal Study of New and Prevalent Use of Self-Monitoring of Blood Glucose Diabetes Care, August 1, 2006; 29(8): 1757 - 1763. [Abstract] [Full Text] [PDF]

				A. J. Karter, D. H. Thom, J. Liu, H. H. Moffet, A. Ferrara, and J. V. Selby Use of Antibiotics Is Not Associated With Decreased Risk of Myocardial Infarction Among Patients With Diabetes Diabetes Care, July 1, 2003; 26(7): 2100 - 2106. [Abstract] [Full Text] [PDF]

				A. J. Karter, A. Ferrara, J. Y. Liu, H. H. Moffet, L. M. Ackerson, and J. V. Selby Ethnic Disparities in Diabetic Complications in an Insured Population JAMA, May 15, 2002; 287(19): 2519 - 2527. [Abstract] [Full Text] [PDF]

				P J Roderick, I Jones, V S Raleigh, M McGeown, and N Mallick Population need for renal replacement therapy in Thames regions: ethnic dimension BMJ, October 29, 1994; 309(6962): 1111 - 1114. [Abstract] [Full Text]

				M. D. Smith, P. P. Purnell, B. A. Hong, and A. M. Robson The Quality of Maintenance Therapy for End-Stage Renal Disease: A Review of Social Adjustment and Rehabilitation Eval Health Prof, December 1, 1983; 6(4): 397 - 412. [Abstract] [PDF]